Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

AMRXAMRX
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in AMNEAL PHARMACEUTICALS INC

GEODE CAPITAL MANAGEMENT, LLC holds 5.1M shares of AMRX (AMNEAL PHARMACEUTICALS INC), worth $89M as of 2026-Q2. The position was increased (+13.1% shares). AMRX represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$89M

Current Shares

5.1M

Total Value Change

+$57.5M

Total Shares Change

+1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.1M
+13.1%
$89M0.0%$17.31
34
2026-Q1
Increased
4.5M
+14.0%
$56.5M0.0%$13.31
33
2025-Q4
Decreased
4M
-1.2%
$50.2M0.0%$12.88
0
2025-Q3
Increased
4M
+7.3%
$40.4M0.0%$9.87
31
2025-Q2
Decreased
3.8M
-1.7%
$30.4M0.0%$8.13
0
2025-Q1
Increased
3.8M
+0.3%
$32.1M0.0%$8.28
29
2024-Q4
Increased
3.8M
+0.7%
$30.2M0.0%$7.83
29
2024-Q3
Increased
3.8M
+11.1%
$31.5M0.0%$8.19
32

Other major holders of AMRX: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, VANGUARD PORTFOLIO MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used